April 28, 2024

Novozymes and Arla Foods Ingredients join forces to harness power of precision fermentation

Biotech and nutrition leaders form partnership to develop advanced protein ingredients

Novozymes and Arla Foods Ingredients have agreed on a partnership to develop advanced protein ingredients using precision fermentation.

Biotechnology company Novozymes is a world leader in precision fermentation. This technique fine-tunes the molecular output of microorganisms, offering greater control over the fermentation process and enabling tailor-made protein compositions. Specializing in the production of enzymes through precision fermentation, it has focused on exploring new protein solutions for health and nutrition since 2019.

In the co-funded partnership with nutrition leader Arla Foods Ingredients, it will contribute its expertise in the creation of microbial strains for the industrial-scale production of proteins by precision fermentation.

This will be combined with Arla Foods Ingredients’ food technology know-how – in particular in relation to separation and drying processes – and its knowledge of the regulatory landscape.

The initial focus of the collaboration will be a solution for disease-specific medical nutrition – a category in which protein is an essential component – with expansion into other segments anticipated in the future.

Henrik Andersen, Group Vice President of Arla Foods Ingredients, said: “This partnership brings together two market leaders in our respective areas. Collaborating with Novozymes fits perfectly with our ambition to explore alternative nutrition platforms and complement our portfolio of dairy and whey solutions. By leveraging our combined expertise, manufacturing skills, and market insights, we’ll be able to accelerate the pace at which we bring innovative new protein products to market.”

Valerio Nannini, General Manager, Novozymes Advanced Protein Solutions, said: “Precision fermentation allows us to do almost anything in terms of protein composition and structure, and this is a fantastic opportunity to harness its full potential. In our ambition to develop new tailor-made products Arla Foods Ingredients is the best possible partner for us. It’s already firmly positioned in medical nutrition and offers substantial insight into market needs, as well as specific manufacturing capabilities that complement ours. Entering a partnership like this demonstrates the huge progress we’ve made since our decision to enter the health and nutrition space.”

Related articles

BENEO Redefines Plant-Based Beef and Minced Meat Innovation at Fi Europe 2023

Fi Europe 2023, 28th-30th Nov, Frankfurt (BENEO Booth 3.1G160) Building on the success of the Meatless B.V. acquisition last year, BENEO is proud to unveil the next milestone in its plant-based journey at Fi Europe 2023. Planned for the beginning of 2024, the ingredient manufacturer will expand its semi-finished product portfolio to include plant-based Meatless®

Microalgae to be developed for nutraceutical applications

Yemoja joins MIGAL Institute to pioneer major study of microalgae for Inflammatory Bowel Disease Microalgae cultivation start-up Yemoja, Ltd. is joining the MIGAL Galilee Research institute to spearhead an extensive, four-year research initiative to identify algae-sourced compounds with the potential to help manage inflammation andInflammatory Bowel Disease (IBD). Select beneficial algae will be developed into